Skip to main content
    A

    Artivion Inc (AORT)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $21.85
    +0.32 (+1.49%)

    Market Cap: $1.04B

    Last updated: Oct 16, 2026 at 1:54 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    69%(27/39)
    Avg Surprise
    +25.00%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.07
    Range$0.03 - $0.11
    5 analysts
    EPS RevisionsNo revisions (7d)
    1
    5
    30d
    EPS Estimate DriftChange to current
    90d ago$0.12-44.2%
    60d ago$0.11-40.0%
    30d ago$0.10-35.1%
    7d ago$0.07-5.7%
    Current$0.07
    Revenue Consensus
    $121M
    Range$118M - $125M
    8 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.11
    Range$0.07 - $0.16
    5 analysts
    Revenue Consensus
    $134M
    Range$123M - $139M
    8 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.11---
    Sep 26EST
    		-$0.07---
    Jun 26
    Reported Aug 6
    		$0.13$0.13+0.00%Beat-45.8%
    Mar 26
    Reported May 7
    		$0.08$0.12-33.33%Miss+33.3%
    Dec 25
    Reported Feb 12
    		$0.17$0.18-5.56%Miss+143.2%
    Sep 25
    Reported Nov 6
    		$0.16$0.15+6.67%Beat+33.3%
    Jun 25
    Reported Aug 7
    		$0.24$0.11+118.18%Beat+242.9%
    Mar 25
    Reported May 5
    		$0.06$0.05+20.00%Beat+0.0%
    Dec 24
    Reported Feb 24
    		$-0.39$0.04-1149.60%Miss-457.8%
    Sep 24
    Reported Nov 7
    		$0.12$0.01+1100.00%Beat+500.0%
    Jun 24
    Reported Aug 8
    		$0.07$0.03+133.33%Beat+16.7%
    Mar 24
    Reported May 6
    		$0.06$0.02+200.00%Beat+200.0%
    Dec 23
    Reported Feb 15
    		$0.11$-0.10+210.00%Beat+10.0%
    Sep 23
    Reported Nov 2
    		$0.02$0.03-33.33%Miss+140.0%
    Jun 23
    Reported Aug 3
    		$0.06$0.02+200.00%Beat+300.0%
    Mar 23
    Reported May 4
    		$0.02$-0.02+200.00%Beat-33.3%
    Dec 22
    Reported Feb 16
    		$0.10$-0.02+600.00%Beat+119.6%
    Sep 22
    Reported Nov 3
    		$-0.05$-0.04-25.00%Miss-66.7%
    Jun 22
    Reported Aug 4
    		$-0.03$0.03-200.00%Miss-125.0%
    Mar 22
    Reported May 5
    		$0.03$-0.01+400.00%Beat+0.0%
    Dec 21
    Reported Feb 17
    		$-0.51$0.04-1375.00%Miss-355.0%
    Sep 21
    Reported Nov 4
    		$-0.03$0.03-200.00%Miss-123.1%
    Jun 21
    Reported Jul 29
    		$0.12$0.07+71.43%Beat+700.0%
    Mar 21
    Reported Apr 29
    		$0.03N/A-70.00%Miss+137.5%
    Dec 20
    Reported Feb 11
    		$0.20$0.03+566.67%Beat+100.0%
    Sep 20
    Reported Nov 4
    		$0.13$-0.04+425.00%Beat+116.7%
    Jun 20
    Reported Jul 30
    		$-0.02N/A+85.71%Beat-118.2%
    Mar 20
    Reported Apr 30
    		$-0.08$0.02-500.00%Miss-300.0%
    Dec 19
    Reported Feb 13
    		$0.10$0.08+25.00%Beat+100.0%
    Sep 19
    Reported Oct 30
    		$0.06$0.06+0.00%Beat-25.0%
    Jun 19
    Reported Jul 30
    		$0.11$0.07+57.14%Beat+10.0%
    Mar 19
    Reported Apr 30
    		$0.04$0.04+0.00%Beat+100.0%
    Dec 18
    Reported Feb 13
    		$0.05N/A-54.55%Miss-54.5%
    Sep 18
    Reported Oct 31
    		$0.08$0.07+14.29%Beat+0.0%
    Jun 18
    Reported Aug 6
    		$0.10$0.07+42.86%Beat-16.7%
    Mar 18
    Reported May 2
    		$0.02$0.03-33.33%Miss-77.8%
    Dec 17
    Reported Mar 7
    		$0.11$0.11+0.00%Beat-8.3%
    Sep 17
    Reported Oct 30
    		$0.08$0.08+0.00%Beat-
    Jun 17
    Reported Jul 24
    		$0.12$0.10+20.00%Beat-
    Mar 17
    Reported Apr 26
    		$0.09$0.04+125.00%Beat-
    Dec 16
    Reported Feb 15
    		$0.12$0.09+33.33%Beat-

    Dividends

    Dividend Metrics

    Forward Yield0.00%
    Forward Annual Dividend$0.00
    Payout Ratio0.00%
    No dividend payments in the selected period.

    Key Metrics

    Valuation
    P/E Ratio40.46EV/EBITDA26.08x
    Price/FCF-115.83xFCF Yield-0.86%
    Profitability
    Profit Margin-0.67%Operating Margin9.01%
    ROE-0.73%ROIC2.19%
    Financial Health
    Debt/Equity0.87xInterest Coverage1.04x
    Current Ratio3.47xQuick Ratio2.51x
    Trading Statistics
    Beta1.22Avg Volume586.05K
    52-Week High$48.2552-Week Low$19.16

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$21.74
    SMA 20$22.41
    SMA 50$25.00
    SMA 200$30.57
    EMA 10$21.85
    EMA 20$22.52
    EMA 50$23.96
    EMA 200$28.70

    MACD

    Line: -0.94Signal: -1.00Hist: 0.06

    ADX

    ADX: 33.1+DI: 17.3-DI: 25.3

    Aroon & PSAR

    Aroon Up12.0
    Aroon Down84.0
    PSAR$20.30

    Bollinger Bands

    Upper Band$24.14
    Lower Band$20.68
    %B Position1546%(Upper)
    Band Width0.34

    RSI (14-Day)

    Neutral
    39.2

    Momentum Oscillators

    Stoch %K42.7
    Stoch %D36.5
    Williams %R-47.1
    ROC (10d)-0.4%
    Momentum-0.08
    CCI (20d)-47.9
    MFI (14d)47.7

    Volatility Measures

    ATR (14d)$0.98(4.5%)
    StdDev (20d)0.87
    Hist Vol31.0%(Moderate)

    Volume Flow

    VWAP$21.96
    OBV11.0M
    AD Line3.8M
    CMF (20d)-0.227

    Volume Metrics

    Avg Vol (20d)581.9K
    Vol Ratio0.9x
    VWMA (20d)$22.55

    Pivot Points

    R3$22.49
    R2$22.12
    R1$21.82
    Pivot Point$21.45
    S1$21.16
    S2$20.79
    S3$20.49

    Advanced Oscillators

    TSI-31.76
    Ultimate Osc43.2
    KST-146.12

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$125.76M$116.34M$115.99M$113.39M$112.97M$98.98M$97.31M$95.78M$98.02M$97.43M$93.67M$87.85M
    Cost of Revenue$45.24M$40.89M$42.85M$38.99M$39.86M$35.40M$35.81M$34.77M$34.70M$34.48M$32.58M$31.58M
    Gross Profit$80.52M$75.45M$73.14M$74.39M$73.11M$63.58M$61.50M$61.01M$63.32M$62.95M$61.09M$56.27M
    Operating Expenses$88.88M$69.66M$62.46M$61.86M$64.73M$61.43M$58.83M$56.62M$56.82M$37.63M$57.92M$57.51M
    R&D$9.05M$8.84M$9.12M$8.08M$7.06M$6.73M$7.40M$6.61M$7.50M$6.95M$7.64M$6.42M
    SG&A$79.83M$60.82M$56.84M$57.28M$57.66M$54.70M$51.43M$50.02M$49.32M$30.69M$50.28M$51.09M
    Operating Income$-8,364,000$5.79M$10.68M$12.54M$8.38M$2.15M$2.67M$4.39M$6.51M$25.31M$3.17M$-1,244,000
    Interest Income$367,000$205,000$311,000$240,000$68,000$144,000$374,000$366,000$353,000$374,000$398,000$339,000
    Interest Expense$7.25M$5.37M$8.19M$6.12M$7.27M$7.66M$9.74M$8.40M$8.30M$11.49M$6.24M$6.60M
    Income Before Tax$-11,699,000$339,000$6.54M$7.06M$3.48M$-2,295,000$-16,602,000$-1,266,000$-2,427,000$12.78M$-591,000$-9,419,000
    Income Tax Expense$1.81M$-1,078,000$4.11M$554,000$2.14M$-1,790,000$-119,000$1.02M$-306,000$5.25M$3.38M$382,000
    Net Income$-13,510,000$1.42M$2.43M$6.50M$1.34M$-505,000$-16,483,000$-2,288,000$-2,121,000$7.53M$-3,975,000$-9,801,000
    EBITDA$1.94M$11.84M$20.18M$18.65M$16.22M$10.67M$-939,000$12.88M$11.41M$29.81M$11.07M$2.60M
    EBIT$-4,813,000$5.50M$14.42M$12.94M$10.68M$5.22M$-7,234,000$6.77M$5.52M$23.90M$5.25M$-3,155,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about AORT

    Government Contracts

    Gov Obligations (TTM)
    $442828
    Gov Obligations / Revenue
    0.1%
    Obligations YoY
    N/A
    Active Awards
    22
    New Awards (TTM)
    19
    Avg Remaining Term
    1.9 mo

    Top agency: Department of Veterans Affairs at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C26126P0847Department of Veterans AffairsDepartment of Veterans Affairs$58250Jun 29, 2026
    36C26126P0655Department of Veterans AffairsDepartment of Veterans Affairs$50250Apr 20, 2026
    36C26126P0339Department of Veterans AffairsDepartment of Veterans Affairs$50250Jan 13, 2026
    36C26126P0253Department of Veterans AffairsDepartment of Veterans Affairs$50250Dec 16, 2025
    36C24226P0116Department of Veterans AffairsDepartment of Veterans Affairs$32995Nov 3, 2025
    36C26126P0763Department of Veterans AffairsDepartment of Veterans Affairs$29800May 26, 2026
    36C25226P0244Department of Veterans AffairsDepartment of Veterans Affairs$29250Feb 18, 2026
    36C26126P0163Department of Veterans AffairsDepartment of Veterans Affairs$25045Nov 14, 2025
    36C25626P0563Department of Veterans AffairsDepartment of Veterans Affairs$19929Apr 8, 2026
    36C25626P0691Department of Veterans AffairsDepartment of Veterans Affairs$19679May 18, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    AORT Valuation and Fair Value

    P/E
    40.5x
    Forward P/E
    35.3x
    EV/EBITDA
    26.1x
    P/FCF
    -115.8x
    PEG
    181.5x
    P/B
    2.4x
    See GNG's fair value

    AORT Profitability: Margins, ROIC and FCF

    Gross margin
    64.4%
    Operating margin
    9.0%
    Net margin
    -0.7%
    ROIC
    2.2%
    ROE
    -0.7%
    FCF margin
    -1.9%
    FCF yield
    -0.9%

    AORT Competitors

    CompanyTicker
    CureVac NVCVAC
    HealthStream IncHSTM
    Janux Therapeutics IncJANX
    Integra LifeSciences HoldingsIART
    Enovis CorpENOV
    Opko Health IncOPK
    Immatics NVIMTX
    Harrow Health IncHROW

    Sector: Healthcare

    AORT Analyst Ratings

    Consensus
    Buy
    Analysts
    8
    Strong Buy
    2
    Buy
    6
    Hold
    0
    Sell
    0
    Strong Sell
    0

    AORT Bull Case vs Bear Case

    Bull case

    • AORT grew quarterly revenue 11.3% year over year.
    • 100.0% of AORT's analyst ratings are Buy or Strong Buy.

    Bear case

    • AORT trades at 40.5x trailing earnings.
    • AORT has a -0.7% net profit margin.

    AORT Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    7.0%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.07
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 5 down

    AORT Dividend

    Forward yield
    0.0%
    Payout ratio
    0.0%

    Frequently Asked Questions About AORT

    Does AORT pay dividends?

    Artivion Inc (AORT) has a dividend payment track record. See the AORT dividend history page for its current payment status, TTM yield, and recorded payments.

    What is AORT's P/E ratio?

    Artivion Inc has a price-to-earnings (P/E) ratio of 40.46.

    What is AORT's market cap?

    Artivion Inc (AORT) has a market capitalization of $1.04B with a current stock price of $21.85.

    Related stocks

    Sector: Healthcare

    All stocks starting with A

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In